[
  {
    "variant_string_id": "EGFR L858R",
    "functional_evidence_aim": "Pathogenic",
    "assessment_steps": [
      {
        "step_name": "Step 1: Define the disease mechanism",
        "extracted_paper_info": "The paper discusses EGFR mutations in lung cancer, indicating that these mutations lead to constitutive activation of the EGFR tyrosine kinase, contributing to uncontrolled cell proliferation. The assay aims to assess the impact of specific mutations on kinase activity.",
        "judgment": "Yes",
        "reasoning": "The paper clearly establishes EGFR mutations as drivers of uncontrolled cell proliferation, highlighting their role in the disease mechanism.",
        "next_step_or_outcome": "Proceed to Step 2"
      },
      {
        "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
        "extracted_paper_info": "The assay described is an in vitro kinase activity assay that measures the phosphorylation rate of a substrate by EGFR. This assay models EGFR signaling pathway activation, which is a core component of the disease mechanism.",
        "judgment": "Yes",
        "reasoning": "The kinase activity assay effectively models the aberrant EGFR signaling pathway, aligning with the established disease mechanism.",
        "next_step_or_outcome": "Proceed to Step 3"
      },
      {
        "step_name": "Step 3: Evaluate validity of specific instances of assays.",
        "extracted_paper_info": "The assay includes wild-type EGFR as a negative control, and a well-characterized loss-of-function mutant (e.g., T790M) as a positive control. Multiple replicates (n=3) were performed for each condition. ",
        "judgment": "Yes",
        "reasoning": "The presence of both wild-type and loss-of-function controls, alongside the mention of multiple replicates, satisfy the basic criteria for assay validity.",
        "next_step_or_outcome": "Proceed to Step 4"
      },
      {
        "step_name": "Step 4: Apply evidence to individual variant interpretation.",
        "extracted_paper_info": "The paper performs statistical analysis and calculates OddsPath values. For EGFR L858R, the OddsPath is reported as 25.4.",
        "judgment": "Yes",
        "reasoning": "Statistical analysis and OddsPath calculation are performed.",
        "next_step_or_outcome": "Determine PS3/BS3 Strength"
      }
    ],
    "final_evidence_strength": {
      "type": "Pathogenic",
      "strength": "PS3_very_strong"
    },
    "overall_conclusion": "The EGFR L858R mutation demonstrates very strong pathogenic evidence due to the robust kinase activity assay with appropriate controls, replication, and a calculated OddsPath of 25.4, which exceeds the threshold for PS3_very_strong."
  }
]